Skip to results
Modify your search
NARROW
1-5 of 5
Authors: Thomas Campbell
Journal Article
995. Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline Open Access
Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Pages S526–S527, https://doi.org/10.1093/ofid/ofaa439.1181
Published: 31 December 2020
Journal Article
1962. Renal Outcomes for Participants Taking F/TAF vs. F/TDF for HIV PrEP in the DISCOVER Trial Open Access
Open Forum Infectious Diseases, Volume 6, Issue Supplement_2, October 2019, Page S64, https://doi.org/10.1093/ofid/ofz359.139
Published: 23 October 2019
Journal Article
Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort Open Access
Open Forum Infectious Diseases, Volume 3, Issue 3, Summer 2016, ofw118, https://doi.org/10.1093/ofid/ofw118
Published: 27 July 2016
Journal Article
Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248 Get access
The Journal of Infectious Diseases, Volume 208, Issue 6, 15 September 2013, Pages 884–891, https://doi.org/10.1093/infdis/jit272
Published: 24 June 2013
Journal Article
The Extraordinary Hope of Antiretroviral Therapy in South Africa (Even for Patients with Tuberculosis or Kaposi Sarcoma!) Get access
The Journal of Infectious Diseases, Volume 191, Issue 3, 1 February 2005, Pages 321–323, https://doi.org/10.1086/427341
Published: 01 February 2005
